1. Home
  2. ONMD vs XLO Comparison

ONMD vs XLO Comparison

Compare ONMD & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OneMedNet Corp

ONMD

OneMedNet Corp

HOLD

Current Price

$1.09

Market Cap

45.8M

Sector

N/A

ML Signal

HOLD

XLO

Xilio Therapeutics Inc.

HOLD

Current Price

$8.25

Market Cap

49.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ONMD
XLO
Founded
2006
2016
Country
United States
United States
Employees
23
76
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
45.8M
49.0M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
ONMD
XLO
Price
$1.09
$8.25
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$28.00
AVG Volume (30 Days)
263.7K
30.5K
Earning Date
05-13-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$43,766,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$168.77
P/E Ratio
N/A
N/A
Revenue Growth
N/A
589.88
52 Week Low
$0.31
$0.46
52 Week High
$4.22
$9.25

Technical Indicators

Market Signals
Indicator
ONMD
XLO
Relative Strength Index (RSI) 68.48 65.79
Support Level $1.04 $0.62
Resistance Level $1.20 $9.22
Average True Range (ATR) 0.09 0.41
MACD 0.01 -0.28
Stochastic Oscillator 67.35 20.65

Price Performance

Historical Comparison
ONMD
XLO

About ONMD OneMedNet Corp

OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. Its technology has provens the commercial and regulatory viability of imaging Real World Data, an emerging market, and provides regulatory-grade, image-centric iRWDTM. Geographically, it operates in Americas, Europe and Middle East, and Asia Pacific. It derives maximum revenue from Europe and Middle East.

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology (I-O) therapies to improve outcomes for people living with cancer. Leveraging its clinically validated masking technology and capabilities, the company develops I-O therapies designed to selectively activate within the tumor microenvironment to achieve durable efficacy without the severe side effects associated with systemically active I-O agents. Its integrated biology and protein engineering approach enables the design and development of potent masked biologics that are activated by tumor-specific proteases.

Share on Social Networks: